Content about Asacol

October 11, 2011
Zacks: Warner Chilcott can withstand generic threats

Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.

November 7, 2010
Warner Chilcott reports Q3 revenue gain, profit drop

Quarterly revenue for Warner Chilcott during the third quarter primarily was driven by the company's...

© 2013 Drug Store News. All Rights Reserved.